Remove tag translational-gap
article thumbnail

Grand Rounds May 12, 2023: Design and Pragmatic Trial of COACH: A Patient Portal/EHR Information System for Home Blood Pressure Monitoring in Hypertension (Richelle J. Koopman, MD, MS)

Rethinking Clinical Trials

It works in the Oregon EPIC EHR, and we are working on translating it to Vanderbilt. Vanderbilt has a plan for bridging this gap through care managers. At MU we have a collaboratory called the Tiger Institution that does programming. They estimated 5,000 hours to put it in the EHR, and they did it for free. We are paying now.

Trials 130
article thumbnail

Grand Rounds August 19, 2022: Inclusion and Diversity in Clinical Trials: Actionable Steps to Drive Lasting Change (Gerald Bloomfield, MD, MPH; Michelle Kelsey, MD)

Rethinking Clinical Trials

For the theme of improving representation and diversity among clinical investigators, having a more representative clinical trial workforce might translate to more diverse participants. This is one of the biggest gaps that we do not have a solution for yet in the clinical trial space. Ask and engage community partners. Learn more.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Meet the Researcher: Andreas Bader, Triumvira Immunologics

Drug Discovery World

We have now our lead product in a Phase I/II study, which is a HER-2 directed tag T cell product for patients with HER-2 positive solid tumours. There’s a huge translational gap going from drug discovery to our in vivo mouse models, and then on to a human subject. Bridging these gaps is absolutely critical.

article thumbnail

Spatial Genomics, Transcriptomics and Proteomics Solutions – An Amelioration of Tissue Analytics

Roots Analysis

Recent advances in multi-omics approaches, including genomics, transcriptomics, proteomics, metabolomics, cytometry and imaging, in combination with bioinformatics and biostatistics, have been translated into several popular bioanalytical platforms, such as next-generation sequencing (NGS), single-cell analysis, flow cytometry and mass spectrometry.

Genome 52